A qualitative exploration of prescription opioid injection among street-based drug users in Toronto: behaviours, preferences and drug availability
Tóm tắt
There is evidence of a high prevalence of prescription opioid (PO) and crack use among street drug users in Toronto. The purpose of this qualitative study was to describe drug use behaviours and preferences as well as the social and environmental context surrounding the use of these drugs among young and old street-based drug injection drug users (IDUs). In-depth interviews were conducted with 25 PO injectors. Topics covered included drug use history, types of drugs used, how drugs were purchased and transitions to PO use. Interviews were taped and transcribed. Content analysis was conducted to identify themes. Five prominent themes emerged from the interviews: 1) Combination of crack and prescription opioids, 2) First injection experience and transition to prescription opioids, 3) Drug preferences and availability, 4) Housing and income and 5) Obtaining drugs. There was consensus that OxyContin and crack were the most commonly available drugs on the streets of Toronto. Drug use preferences and behaviours were influenced by the availability of drugs, the desired effect, ease of administration and expectations around the purity of the drugs. Distinct experiences were observed among younger users as compared to older users. In particular, the initiation of injection drug use and experimentation with POs among younger users was influenced by their experiences on the street, their peers and general curiosity. Given the current profile of street-based drug market in Toronto and the emergence of crack and POs as two predominant illicit drug groups, understanding drug use patterns and socio-economic factors among younger and older users in this population has important implications for preventive and therapeutic interventions.
Tài liệu tham khảo
Fischer B, Firestone Cruz M, Rehm J: Illicit opioid use and its key characteristics: A select overview and evidence from a Canadian multi-site cohort of illicit opioid users (OPICAN). Can J Psychiatry. 2006, 51 (10): 624-34.
Cicero TJ, Inciardi JA, Munoz A: Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004. Journal of Pain. 2005, 6 (10): 662-72. 10.1016/j.jpain.2005.05.004.
Health Canada: I-Track: Enhanced Surveillance of Risk Behaviours among Injecting Drug Users in Canada (Pilot Survey Report). 2004, Ottawa: Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Population and Public Health Branch, Health Canada
Fischer B, Monga N, Manzoni P: Differences between co-users of cocaine and crack among Canadian illicit opioid users. Sucht. 2005, 51 (4): 217-24.
Health Canada: Reducing the harm associated with injection drug use in Canada. 2001, Ottawa: Health Canada
Remis R, Leclerc P, Routledge R, Taylor C, Bruneau J, Beauchemin J, Millson P, Palmer R, Degani N, Strathdee S, Hogg R: Consortium to characterize injection drug users in Canada (Montreal, Toronto and Vancouver). 1998, Toronto: Self-published
Compton W, Volkow N: Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend. 2006, 81: 103-7. 10.1016/j.drugalcdep.2005.05.009.
Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C: College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003, 69 (3): 215-32. 10.1016/S0376-8716(03)00003-6.
International Narcotics Control Board: Narcotic Drugs: Estimated World Requirements for 2008. New York. 2008
Brands B, Blake J, Sproule B, Gourlay D, Busto U: Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend. 2004, 73 (2): 199-207. 10.1016/j.drugalcdep.2003.10.012.
Fischer B, Rehm J, Patra J, Firestone Cruz M: Changes in illicit opioid use across Canada. CMAJ. 2006, 175 (11): 1385-
Adlaf E, Paglia A: Drug Use Among Ontario Students 1997–2007: OSDUHS. 2007
OxyContin Task Force: OxyContin Task Force: Final Report. Newfoundland and Labrador. 2004
Fischer B, Rehm J, Brissette S, Brochu S, Bruneau J, el-Guebaly N, Noël L, Tyndall M, Wild C, Mun P, Baliunas D: Illicit opioid use in Canada: Comparing social, health and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health. 2005, 82 (2): 250-66.
Fischer B, Medved W, Gliksman L, Rehm J: Illicit opiates in Toronto: a profile of current users. Addiction Research. 1999, 7 (5): 377-415. 10.3109/16066359909004395.
Monga N, Rehm J, Fischer B, Brissette S, Bruneau J, el-Guebaly N, Noel L, Tyndall M, Wild C, Leri F, Fallu JS, Bahl S: Using Latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend. 2007, 88 (1): 1-8. 10.1016/j.drugalcdep.2006.08.029.
Powis B, Strang J, Griffiths P, Taylor C, Williamson S, Fountain J, Gossop M: Self-reported overdose among injecting drug users in London: extent and nature of the problem. Addiction. 1999, 94 (4): 471-8. 10.1046/j.1360-0443.1999.9444712.x.
Brugal M, Barrio G, de la Fuente L, Regidor E, Royuela L, Suelves J: Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction. 2002, 97: 319-27. 10.1046/j.1360-0443.2002.00058.x.
Griffiths P, Gossop M, Powis B, Strang J: Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction. 1994, 89: 301-9. 10.1111/j.1360-0443.1994.tb00896.x.
Bravo MJ, Barrio G, de la Fuente L, Royuela L, Domingo L, Silva T: Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic. Addiction. 2003, 98 (6): 749-60. 10.1046/j.1360-0443.2003.00393.x.
Strang J, Griffiths P, Powis B, Abbey J, Gossop M: How constant is an individual's route of heroin administration? Data from treatment and non-treatment samples. Drug Alcohol Depend. 1997, 46: 115-8. 10.1016/S0376-8716(97)00035-5.
Darke S, Cohen J, Ross J, Hando J, Hall W: Transitions between routes of administration of regular amphetamine users. Addiction. 1994, 89: 1077-83. 10.1111/j.1360-0443.1994.tb02784.x.
Strang J, Griffiths P, Powis B, Gossop M: Heroin chasers and heroin injectors: Differences observed in a community sample in London, UK. Am J Addict. 1999, 8 (2): 148-60. 10.1080/105504999305956.
Neaigus A, Miller M, Friedman S, Hagen D, Sifaneck S, Ildefonso G, Des Jarlais D: Potential risk factors for the transition to injection among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction. 2001, 96: 847-60. 10.1046/j.1360-0443.2001.9668476.x.
Sherman SG, Smith L, Laney G, Strathdee SA: Social Influences on the transition to injection drug use among young heroin sniffers: a qualitative analysis. Int J Drug Policy. 2002, 13: 113-20. 10.1016/S0955-3959(02)00010-5.
Crofts N, Louie R, Rosenthal D, Jolley D: The first fit: Circumstances surrounding initiation into injecting. Addiction. 1996, 91 (8): 1187-96. 10.1046/j.1360-0443.1996.918118710.x.
van Ameijden E, Hoek van den J, Hartgers C, Coutinho R: Risk factors for the transition from non-injection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol. 1994, 139: 1153-63.
de la Fuente L, Saavedra P, Barrio G, Royuela L, Vicente J: Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Spanish Group for the Study of the Purity of Seized Drugs. Drug Alcohol Depend. 1996, 40 (3): 185-94. 10.1016/0376-8716(95)01208-7.
Latkin C, Knowlton A, Sherman S: Routes of drug administration, differential affiliation, and lifestyle stability among cocaine and opiate users: Implications to HIV prevention. J Subst Abuse. 2001, 13: 89-102. 10.1016/S0899-3289(01)00070-0.
Quaglio G, Lugoboni F, Pajusco B, Sarti M, Talamini G, Lechi A, Mezzelani P, Des Jarlais DC: Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy. Clin Infect Dis. 2003, 37 (1): 33-40. 10.1086/375566.
Andersen HS, Sestoft D, Lillebaek T, Gabrielsen G, Hemmingsen R: Heroin dependence: Consequences and precursors related to route of administration. Nord J Psychiatry. 1999, 53 (2): 153-8. 10.1080/080394899426873.
Chitwood DD, Comerford M, Sanchez J: Prevalence and risk factors for HIV among sniffers, short-term injectors, and long-term injectors of heroin. J Psychoactive Drugs. 2003, 35 (4): 445-53.
Watters JK, Biernacki P: Targeted sampling: Options for the study of hidden populations. Social Problems. 1989, 36: 416-30. 10.1525/sp.1989.36.4.03a00070.
Krippendorff K, Content Analysis: An Introduction to its Methodology. 2000, Sage Publications Inc, Second
Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD: Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 2007, 90 (1): 64-71. 10.1016/j.drugalcdep.2007.02.012.
Inciardi J, Surratt H, Kurtz S, Cicero T: Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med. 2007, 8 (2): 171-83. 10.1111/j.1526-4637.2006.00255.x.
Health Canada: Report on the Review of Sales Transactions for Oxycodone-based Products in Atlantic Canada. 2005
Kerr T, Stoltz J, Tyndall M, Li K, Zhang R, Montaner JS, Wood E: Impact of a Medically Supervised Safer Injection Facility on Community Drug Use Patterns: A Before and After Study. BMJ. 2006, 332: 220-2. 10.1136/bmj.332.7535.220.
Wood E, Tyndall M, Qui Z, Zhang R, Montaner JS, Kerr T: Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. Am J Public Health. 2006, 96 (5): 770-3. 10.2105/AJPH.2004.057828.
Toronto Drug Strategy: The Toronto Drug Strategy: A Comprehensive Approach to Alcohol and other Drugs. 2005
Toronto Drug Strategy: Toronto Drug Strategy: Status Report 2008. 2008, Toronto: Toronto Drug Strategy Secretariat
Safer Crack Use Coalition: Wellesley project: Data from crack users in Toronto. 2004, Toronto: Safer Crack Use Coalition
Safer Crack Use Coalition: Toronto Crack Users Perspectives: Inside, Outside, Upside Down. 2005, Toronto: Safer Crack Use Coalition
Siqueland L, Crits-Christoph P, Barber J, Connoly Gibbens M, Gallop R, Griffin M, Frank A, Thase M, Luborsky L, Liese B: What aspects of treatment matter to the patient in the treatment of cocaine dependence?. J Subst Abuse Treat. 2004, 27: 169-78. 10.1016/j.jsat.2004.06.007.
Brink van den W: Epidemiology of cocaine and crack: Implications for drug policy and treatment planning. Sucht. 2005, 51 (4): 196-8.
Fischer B, Haydon E, Rehm J, Krajden M, Reimer J: Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach – the case study of Canada. J Urban Health. 2004, 81 (3): 428-47.
Novelli LA, Sherman GS, Havens JRL, Strathdee SA, Sapun M: Circumstances surrounding the first injection experience and their association with future syrine sharing behaviors in young urban injection drug users. Drug Alcohol Depend. 2005, 77: 303-9. 10.1016/j.drugalcdep.2004.08.021.
Kuo I, Sherman SG, Thomas DL, Strathdee SA: Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection. Drug Alcohol Depend. 2004, 73 (1): 69-78. 10.1016/j.drugalcdep.2003.10.007.
Darke S, Hall W: Heroin overdose: research and evidence-based intervention. J Urban Health. 2003, 80 (2): 189-200.
Hunt N, Stillwell G, Taylor C, Griffiths P: Evaluation of a brief intervention to prevent initiation into injecting drugs. Drugs Education Prevention Policy. 1998, 5: 185-94.
Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E: Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abuse Treat. 1990, 7: 1-10. 10.1016/0740-5472(90)90031-K.
Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D: Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1998, 18 (Suppl 1): S11-S19.
Andrade X, Sifaneck SJ, Neaigus A: Dope Sniffers in New York City: An Ethnography of Heroin Markets and Patterns of Use. J Drug Issues. 1999, 29 (2): 271-98.
Rhodes T, Mikhailova L, Sarang A, Lowndes CM, Rylkov A, Khutorskoy M, Renton A: Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitatitve study of micro risk environment. Social Science and Medicine. 2003, 57: 39-54. 10.1016/S0277-9536(02)00521-X.
Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano D: The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users; the SAFE study. American Journal of Community Psychology. 1996, 24: 109-21. 10.1007/BF02512026.
Fagan J, Ko-lin C: Social Processes of Initiation into Crack. J Drug Issues. 1991, 21 (2): 313-43.